Prostate Cancer News on BioPortfolio

Warringtonbased biotech firm Arcis Biotechnology Group is bidding to raise £2m to step up research and development for revolutionary prostate cancer testing. It will and accelerate commercial rollout of groundbreaking test of rapid DNARNA extraction

Warringtonbased biotech firm Arcis Biotechnology Group is bidding to raise £2m to step up research and development for revolutionary prostate cancer testing.It will and accelerate commercial rollout of groundbreaking test of rapid DNARNA extracti...

Recent Reports About HIFU 'Troubling'

Despite new reports of HIFU for focalized therapy of prostate cancer Dr Chodak remains unconvinced of its evidence. Medscape Urology

Docetaxel for Prostate Cancer 'WinWinWin'

In both metastatic and nonmetastatic patients the chemotherapy improved three important outcomes compared with previous standard of care. Medscape Medical News

J&J's apalutamide shows strength in nonmetastatic prostate cancer

Johnson & Johnson unveiled new data at the ASCO Genitourinary Cancer symposium which demonstrated that its androgen receptor antagonist apalutamide significantly improved median metastasisfree survival MFS by two years compared to placebo in patien...

CR Pharma Inlicenses Rights To Prostate Cancer Drug from Xbrane

China Resource Pharmaceutical Group acquired China rights to a longacting treatment for prostate cancer developed by Sweden's Xbrane Biopharma. Spherotide is triptorelin a GnRH analogue in a parenteral depot formulation. CR Pharma will pay an initial licen...

Versatile sensor against tumor initiating cells

Institute for Basic Science The IBS researchers developed the first fluorescent sensor to visualize TICs. Functional in lung central nervous system melanoma breast renal ovarian colon and prostate cancer cell cultures this could become a useful tool for bi...

Pages